USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ANGIOGENEX
City: NEW YORK
State: NY
Zip+4: 10017-1110
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $163,150.00 1

Award List:

Studies in Mice to Improve Efficacy/Safety of Paclitaxel/Docetaxel with an Anti-I

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: William A. Garland
Award Amount: $163,150.00
Abstract:
DESCRIPTION (provided by applicant): Inhibitor of differentiation (Id) genes and proteins play a significant role in tumor biology, and an anti-Id therapy in combination with a taxanes, a widely prescribed class of cytotoxic (paclitaxel/docetaxel, docetaxe l or protein-bound paclitaxel) to treat… More